Literature DB >> 11179432

Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract.

R H Tukey1, C P Strassburg.   

Abstract

The metabolism of ingested foods and orally administered drugs occurs in the hepato-gastrointestinal tract. This process is facilitated by several supergene families that catalyze oxidative metabolism as well as conjugation of the small molecular weight substances that enter the systemic circulation through resorption in the gastrointestinal tract. The catalytic action carried out by one of several conjugation reactions leads to the eventual elimination of the resultant metabolites from the cell. As early as 1959 (R. T. Williams, Detoxification Mechanisms) it was suggested that the detoxification of most agents is efficiently performed by the phase II conjugation reactions, because the addition of bulky, water-soluble groups to the target substrates facilitates the partitioning of these metabolites from the lipid into the aqueous compartments of the cell. The combined efforts of the phase II reactions provides remarkable redundancy in a biological system that seems to be designed to assure that many endogenously generated catabolic products as well as exogenous agents introduced through the surface tissues of the digestive tracts are efficiently removed through excretion to the bile or urine. In this review, we focus on recent findings that highlight the genetic multiplicity and regulatory patterns of the phase II superfamily UDP-glucuronosyltransferases (UGTs). Although much is known regarding the number of UGTs that make up the UGT1 and UGT2 gene families, as demonstrated after the characterization of expressed cDNAs, examples are also presented in which information obtained from the human genome project will aid in the final characterization of the genetic multiplicity. In addition, tools have now been developed and examples presented to identify the expression patterns of the UGTs in human tissues, paying particular attention to expression patterns of these genes in the hepato-gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179432     DOI: 10.1124/mol.59.3.405

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  41 in total

Review 1.  Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.

Authors:  Jacqueline Ramírez; Mark J Ratain; Federico Innocenti
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

2.  Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.

Authors:  Jacqueline Ramírez; Snezana Mirkov; Larry K House; Mark J Ratain
Journal:  Drug Metab Dispos       Date:  2015-04-13       Impact factor: 3.922

3.  Studies on induction of lamotrigine metabolism in transgenic UGT1 mice.

Authors:  U A Argikar; K Senekeo-Effenberger; E E Larson; R H Tukey; R P Remmel
Journal:  Xenobiotica       Date:  2009-11       Impact factor: 1.908

4.  Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid.

Authors:  Martijn G H van Oijen; Sylvie Huybers; Wilbert H M Peters; Joost P H Drenth; Robert J F Laheij; Freek W A Verheugt; Jan B M J Jansen
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

5.  UDP-glucuronosyltransferase 1A4 (UGT1A4) polymorphisms in a Jordanian population.

Authors:  Nancy Hakooz; Sameh Alzubiedi; Al-Motassem Yousef; Tawfiq Arafat; Rana Dajani; Nidaa Ababneh; Said Ismail
Journal:  Mol Biol Rep       Date:  2012-02-25       Impact factor: 2.316

6.  UGT2B gene expression analysis in multiple tobacco carcinogen-targeted tissues.

Authors:  Nathan R Jones; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2014-01-23       Impact factor: 3.922

7.  Farnesol is glucuronidated in human liver, kidney and intestine in vitro, and is a novel substrate for UGT2B7 and UGT1A1.

Authors:  Adam G Staines; Pavel Sindelar; Michael W H Coughtrie; Brian Burchell
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

8.  Relative importance of intestinal and hepatic glucuronidation-impact on the prediction of drug clearance.

Authors:  Helen E Cubitt; J Brian Houston; Aleksandra Galetin
Journal:  Pharm Res       Date:  2009-01-31       Impact factor: 4.200

9.  Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression.

Authors:  Dione Gardner-Stephen; Jean-Marie Heydel; Amit Goyal; Yuan Lu; Wen Xie; Tim Lindblom; Peter Mackenzie; Anna Radominska-Pandya
Journal:  Drug Metab Dispos       Date:  2004-03       Impact factor: 3.922

10.  Cloning and comparative analyses of the zebrafish Ugt repertoire reveal its evolutionary diversity.

Authors:  Haiyan Huang; Qiang Wu
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.